ORAOV1 antibody (AA 31-137)
-
- Target See all ORAOV1 products
- ORAOV1 (Oral Cancer Overexpressed 1 (ORAOV1))
-
Binding Specificity
- AA 31-137
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This ORAOV1 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Predicted Reactivity
- Human,Mouse,Rat,Dog,Cow,Pig,Horse
- Purification
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human ORAV1 (31-75aa)
- Isotype
- IgG
-
-
- Application Notes
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Expiry Date
- 12 months
-
- Target
- ORAOV1 (Oral Cancer Overexpressed 1 (ORAOV1))
- Alternative Name
- ORAV1 (ORAOV1 Products)
- Synonyms
- TAOS1 antibody, 2210010N10Rik antibody, oral cancer overexpressed 1 antibody, ORAOV1 antibody, Oraov1 antibody
- Background
-
Synonyms: Oral cancer overexpressed 1, Oral cancer overexpressed protein 1 A, ORAOV1 oral cancer overexpressed 1, TAOS1, Tumor amplified and overexpressed sequence 1, ORAV1_HUMAN.
Background: ORAV1
-